Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Lukang Sanye Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the Shandong Lukang Pharmaceutical Group. The company specializes in the production of finished dosage forms, including tablets, capsules, and granules, with a primary focus on anti-infectives, cardiovascular medications, and metabolic disease treatments. Operating from large-scale, GMP-certified facilities in Jining, the company serves as a critical link in the Lukang Group's integrated supply chain, converting active pharmaceutical ingredients into high-quality clinical products. Its portfolio includes widely used essential medicines such as amoxicillin, metformin, and amlodipine, which are distributed across domestic and international markets. Lukang Sanye is recognized for its robust manufacturing capacity and its contribution to the parent group's status as a leader in the Chinese antibiotic industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Lukang Sanye Pharmaceutical.